India · Delayed Price · Currency is INR Transgene Biotek Statistics
Total Valuation
BOM:526139 has a market cap or net worth of INR 196.24 million. The enterprise value is 360.68 million.
| Market Cap | 196.24M |
| Enterprise Value | 360.68M |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:526139 has 75.77 million shares outstanding. The number of shares has increased by 1.34% in one year.
| Current Share Class | 75.77M |
| Shares Outstanding | 75.77M |
| Shares Change (YoY) | +1.34% |
| Shares Change (QoQ) | -3.76% |
| Owned by Insiders (%) | 33.21% |
| Owned by Institutions (%) | 8.28% |
| Float | 50.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -38.75 |
| PB Ratio | 2.13 |
| P/TBV Ratio | 7.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -18.89 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.76 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -6.69% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.53% in the last 52 weeks. The beta is 0.40, so BOM:526139's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -41.53% |
| 50-Day Moving Average | 2.63 |
| 200-Day Moving Average | 3.78 |
| Relative Strength Index (RSI) | 57.10 |
| Average Volume (20 Days) | 112,589 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:526139 had revenue of INR -5.06 million and -19.09 million in losses. Loss per share was -0.26.
| Revenue | -5.06M |
| Gross Profit | -5.06M |
| Operating Income | -17.17M |
| Pretax Income | -19.09M |
| Net Income | -19.09M |
| EBITDA | -16.23M |
| EBIT | -17.17M |
| Loss Per Share | -0.26 |
Balance Sheet
The company has 564,000 in cash and 165.00 million in debt, with a net cash position of -164.44 million or -2.17 per share.
| Cash & Cash Equivalents | 564,000 |
| Total Debt | 165.00M |
| Net Cash | -164.44M |
| Net Cash Per Share | -2.17 |
| Equity (Book Value) | 92.08M |
| Book Value Per Share | 1.19 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 339.10% |
| Pretax Margin | 376.97% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:526139 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.34% |
| Shareholder Yield | -1.34% |
| Earnings Yield | -9.73% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |